Detalhe da pesquisa
1.
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Cancer Immunol Immunother
; 73(8): 142, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38832989
2.
A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues.
Proteomics
; 22(7): e2100228, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902229
3.
LncRNA PVT1 is increased in renal cell carcinoma and affects viability and migration in vitro.
J Clin Lab Anal
; 36(6): e24442, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35441392
4.
Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR).
Oncologist
; 26(7): 560-e1103, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829609
5.
MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma.
Clin Chem Lab Med
; 56(9): 1426-1431, 2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451857
6.
The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab.
Tumour Biol
; 39(7): 1010428317709283, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28714375
7.
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry.
BMC Cancer
; 17(1): 880, 2017 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29268716
8.
[Cancer Treatment-induced Changes in Renal Function in Patients with Tumors - Update on Current Knowledge]. / Protinádorovou lécbou indukované zmeny renálních funkcí u pacientu s tumory - update aktuálních poznatku.
Klin Onkol
; 31(1): 28-34, 2017.
Artigo
em Tcheco
| MEDLINE | ID: mdl-29488775
9.
MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.
Tumour Biol
; 37(11): 14653-14658, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27619681
10.
High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib.
Tumour Biol
; 36(12): 9215-22, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26088452
11.
Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy.
Target Oncol
; 19(2): 175-180, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308662
12.
Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
Case Rep Oncol
; 17(1): 537-542, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577248
13.
MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
Tumour Biol
; 34(1): 481-91, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23150176
14.
Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
Genes Chromosomes Cancer
; 51(7): 707-16, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22492545
15.
Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma.
J Cancer Res Clin Oncol
; 149(10): 7587-7600, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988708
16.
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma.
Target Oncol
; 18(6): 893-903, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957520
17.
Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
J Transl Med
; 10: 55, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22440013
18.
Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 166(1): 97-104, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252116
19.
Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy.
Diagnostics (Basel)
; 12(7)2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35885644
20.
The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency: Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?
Medicine (Baltimore)
; 100(24): e26381, 2021 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34128899